[1]
“Cost-effectiveness of dabigatran for stroke prevention in atrial fibrillation in Switzerland”, Swiss Med Wkly, vol. 143, no. 0102, p. w13732, Dec. 2012, doi: 10.4414/smw.2013.13732.